Theravance Biopharma Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Sell

TBPH
Theravance Biopharma

Last Price:

$11.61

Seasonality Move:

-3.18%

7 Day Trial

ALL ACCESS PASS

$ 7

Theravance Biopharma Stock Forecast

Over the next 52 weeks, Theravance Biopharma has on average historically risen by 0.6% based on the past 11 years of stock performance.
Theravance Biopharma has risen higher in 5 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 45.45%
Is Theravance Biopharma Stock Undervalued?

The current Theravance Biopharma [TBPH] share price is $11.65. The Score for TBPH is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
TBPH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Theravance Biopharma Stock Go Up Next Year?

Over the next 52 weeks, Theravance Biopharma has on average historically risen by 0.6% based on the past 11 years of stock performance.

Theravance Biopharma Stock Rating

Sell

Theravance Biopharma (TBPH) is a Sell

Is Theravance Biopharma overpriced?

Theravance Biopharma has risen higher in 5 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 45.45%

Theravance Biopharma Stock Price History

Is TBPH stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TBPH is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

theravance.com

52-Week Data

52-Week High:

11.82

52-Week Low:

7.44

Prediction Charts

Market Cap:

582.5M

Price in USD:

11.65

Volume:

199.5K

Beta:

0.73

Technical Analysis

SMA50:

10.37

SMA100:

9.80

SMA200:

9.45

52-Wk Change:

16.62%

Stock Predictions

Is Theravance Biopharma stock public?

Yes, Theravance Biopharma is a publicly traded company.
What is the Theravance Biopharma stock quote today?

The Theravance Biopharma stock price is 11.65 USD today.
How to buy Theravance Biopharma stock online?

You can buy Theravance Biopharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Jun-26	10.70	10.73	10.80	10.58
Jun-27	10.95	11.22	11.44	10.83
Jun-30	11.22	11.03	11.37	11.00
Jul-1	11.00	10.91	11.12	10.87
Jul-2	10.91	11.05	11.17	10.91
Jul-3	11.08	11.15	11.25	11.00
Jul-7	11.11	11.31	11.32	10.95
Jul-8	11.31	11.22	11.34	11.15
Jul-9	11.26	11.59	11.68	11.18
Jul-10	11.54	11.46	11.59	11.23
Jul-11	11.41	11.30	11.41	11.25
Jul-14	11.27	11.47	11.48	11.24
Jul-15	11.46	11.53	11.55	11.36
Jul-16	11.57	11.65	11.68	11.46

Theravance Biopharma Earnings

Theravance Biopharma Earnings Report: Per Share Theravance Biopharma Earnings Q1 Q2 Q3 and Q4 last year and next year.

Theravance Biopharma Forecast Revenue Growth

Theravance Biopharma Stock Analysis: Historical quarterly revenues per share for Theravance Biopharma and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.50 per share, and a decrease next year of $0.37 per share.

* Theravance Biopharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.